If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ABRILADA adalimumab 40 mg solution for injection pre-filled pen AUST R: 334497Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
From
01 May 2026
to
26 Jun 2026
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
Alternative brands are available.
|
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector AUST R: 384975Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Samsung Bioepis AU Pty Ltd
Phone:
0409454585
|
From
28 Apr 2026
to
03 May 2026
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Transport / Logistic issues / Storage capacity issues
Management action:
Alternative brands are available.
|
ABRILADA adalimumab 20 mg solution for injection pre-filled syringe AUST R: 334496Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
02 Feb 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
ABRILADA adalimumab 40 mg solution for injection pre-filled syringe AUST R: 334498Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
Deletion from market:
01 Apr 2026
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
ADALICIP adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen AUST R: 374376Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
Deletion from market:
01 Jun 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative brands are available.
|
AMGEVITA adalimumab (rch) 20mg/0.4mL injection solution syringe AUST R: 278702Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
31 Aug 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by AMGEVITA adalimumab (rch) 20mg/0.2mL injection solution syringe (ARTG ID 484565)
|
AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe AUST R: 278701Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
31 Aug 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by AMGEVITA adalimumab (rch) 40mg/0.4mL injection solution syringe (ARTG ID 484554)
|
AMGEVITA adalimumab (rch) 40mg/0.8mL injection solution syringe within a pen injector AUST R: 273536Active ingredients:
Adalimumab
Dosage form:
Injection, solution
Sponsor:
Amgen Australia Pty Ltd
Phone:
1800 803 638
|
Deletion from market:
31 Aug 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by AMGEVITA adalimumab (rch) 40mg/0.4mL injection solution syringe within a pen injector (ARTG ID 484553)
|